VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 48 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $90,791 | +4439.6% | 11,715 | +7869.4% | 0.01% | – |
Q4 2019 | $2,000 | 0.0% | 147 | +36.1% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 108 | -9.2% | 0.00% | – |
Q2 2019 | $3,000 | +200.0% | 119 | +58.7% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 75 | -52.2% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 157 | +282.9% | 0.00% | – |
Q3 2018 | $1,000 | -88.9% | 41 | -91.8% | 0.00% | -100.0% |
Q1 2018 | $9,000 | -62.5% | 500 | -76.7% | 0.00% | -66.7% |
Q2 2016 | $24,000 | – | 2,143 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |